|
Re: Epigenetics market to reach $16.3 Billion in 6 years (article)
|
3
|
Resverlogix Corp.
|
Jan 18, 2016 05:57PM
|
|
Re: American Society of Nephrology Kidney Week
|
3
|
Resverlogix Corp.
|
Nov 04, 2017 04:14PM
|
|
Re: Rough Transcript - 2021_06_22_AGM
|
3
|
Resverlogix Corp.
|
Jun 22, 2021 06:22PM
|
|
Re: So, the mood this week was.
|
3
|
Resverlogix Corp.
|
Aug 25, 2021 06:54PM
|
|
Re: No mention of efficacy again...
|
3
|
Resverlogix Corp.
|
Mar 29, 2019 03:12PM
|
|
Re: Is volume going to turn the corner?
|
3
|
Resverlogix Corp.
|
Nov 08, 2019 10:21AM
|
|
Re: A comment about market penetration
|
3
|
Resverlogix Corp.
|
Mar 19, 2017 01:16PM
|
|
Re: My conversation with Don....
|
3
|
Resverlogix Corp.
|
Dec 04, 2017 10:01AM
|
|
Re: Lot's to be excited about!
|
3
|
Resverlogix Corp.
|
Sep 01, 2017 02:13PM
|
|
Re: Resverlogix Closes Extension of Maturity Date of Loan and Announces Private Placement
|
3
|
Resverlogix Corp.
|
Sep 05, 2017 01:50PM
|
|
Re: Eversana ValuationCaseStudy
|
3
|
Resverlogix Corp.
|
Jan 04, 2022 01:16PM
|
|
Re: What if
|
3
|
Resverlogix Corp.
|
Mar 06, 2019 03:23PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
3
|
Resverlogix Corp.
|
May 15, 2022 07:06PM
|
|
Re: It was a little frustrating....
|
3
|
Resverlogix Corp.
|
Jan 12, 2018 12:25PM
|
|
Re: Q2 Zenith/Resverlogix Events
|
3
|
Zenith Epigenetics
|
Apr 13, 2016 08:53AM
|
|
Statistical Considerations
|
3
|
Resverlogix Corp.
|
Mar 05, 2018 01:55PM
|
|
Re: High Finance
|
3
|
Resverlogix Corp.
|
Aug 25, 2019 02:41PM
|
|
Re: Zenith poster from AACR EORTC meeting and Annual General/Special meeting date
|
3
|
Resverlogix Corp.
|
Nov 15, 2015 10:33AM
|
|
Re: New Zenith Drug ZEN-3365 Publication
|
3
|
Zenith Epigenetics
|
Aug 04, 2021 06:09PM
|
|
Re: RVX ...looking bullish
|
3
|
Resverlogix Corp.
|
Aug 18, 2015 11:53AM
|
